Vitamin C and Vitamin D in COVID-19 Therapy

Abstract

Coronavirus disease 2019 (COVID-19) is a disease that can lead to a broad spectrum clinical picture, from asymptomatic course caused by SARS-CoV-2 virus, accompanied by respiratory failure and may result in death. The number of proven therapeutic options for the prevention and treatment of COVID-19 is limited. Vitamin and mineral deficiencies during viral infections are associated with adverse clinical outcomes. Clinical studies are indicating that vitamin supplementation can reduce the incidence and severity of acute respiratory infections. With the COVID-19 pandemic, researches on the benefits of vitamins in disease prevention and treatment have increased. Although some studies report that vitamins are effective, it is observed that there are studies that do not support this statement. Vitamin D plays an important role in enhancing the physical barrier against viruses, stimulating the production of antimicrobial peptides, and preventing cytokine storms by reducing inflammatory cytokine production. It is stated that vitamin C application can increase survival rates by contributing to enhancing the imune response in COVID-19 patients. The purpose of this review is to evaluate the role of vitamin C and vitamin D in COVID-19.

Keywords

• Vitamin D
• Vitamin C
• Covid 19

COVID-19 Tedavisinde Vitamin C ve D

Abstract

Coronavirüs hastalığı 2019 (COVID-19) SARS-CoV-2 virüsünün neden olduğu asemptomatik seyirden, solunum yetmezliğinin eşlik ettiği ve ölümle sonuçlanabilen geniş spektrumda klinik tabloya yol açan hastalıktır. Korunma ve tedavisinde etkinliği kanıtlanmış seçenek sayısı sınırlıdır. Viral enfeksiyonlar sırasında vitamin ve mineral eksiklikleri olumsuz klinik sonuçlarla ilişkilendirilmektedir. Vitamin takviyesinin akut solunum yolu enfeksiyonu insidansını ve şiddetini azaltabileceğini belirten klinik çalışmalar mevcuttur. COVID-19 pandemisiyle birlikte vitaminlerin hastalıktan korunma ve tedavideki yararlarıyla ilgili araştırmalar artmış olup etkin olduğunu bildiren yayınlar kadar, bu sonucu desteklemeyen çalışmaların da olduğu gözlenmektedir. D vitamininin virüslere karşı fiziksel bariyerin güçlendirilmesinde, antimikrobiyal peptitlerin üretiminin uyarılmasında ve inflamatuvar sitokin üretiminin azalmasını sağlayarak sitokin fırtınalarının önlenmesinde önemli rolü olduğu belirtilmektedir. Vitamin C uygulamasının COVID-19 hastalarında immün yanıtın güçlendirilmesine katkıda bulunarak sağ kalım oranlarını arttırabileceği ifade edilmektedir. Bu derlemenin amacı COVID-19 hastalığında C ve D vitaminlerinin yararının değerlendirilmesidir.

Keywords

• Vitamin C
• Vitamin D
• COVID 19

Supporting Institution

Yok

References

1. 1. Shakoor H, Feehan J, Al Dhaheri AS, Ali HI, Platat C, Ismail LC, et al. Immune-boosting role of vitamins D, C, E, zinc, selenium and omega-3 fatty acids: Could they help against COVID-19? Maturitas. 2021;143:1-9.
2. 2. Wang Y, Wang Y, Chen Y, Qin Q. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 2020;92(6):568-76.
3. 3. Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, Alcala Diaz JF, Lopez Miranda J, Bouillon R, et al. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study". J Steroid Biochem Mol Biol. 2020;203:105751.
4. 4. Deluca HF. History of the discovery of vitamin D and its active metabolites. Bonekey Rep. 2014;3:479.
5. 5. Edwards M, Cole Z, Harvey N, Cooper CJJARCP. The global epidemiology of vitamin D status. 2014;3(3):148-58.
6. 6. Charoenngam N, Shirvani A, Holick MF. Vitamin D and Its Potential Benefit for the COVID-19 Pandemic. Endocr Pract. 2021.
7. 7. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol. 2008;181(10):7090-9.
8. 8. Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, et al. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009;183(9):5458-67.

9. 9. Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol. 2014;144 Pt A:138-45.
10. 10. Sizar O, Khare S, Goyal A, Bansal P, Givler A. Vitamin D Deficiency. StatPearls. Treasure Island (FL)2021.
11. 11. Yisak H, Ewunetei A, Kefale B, Mamuye M, Teshome F, Ambaw B, et al. Effects of Vitamin D on COVID-19 Infection and Prognosis: A Systematic Review. Risk Manag Healthc Policy. 2021;14:31-8.
12. 12. D'Avolio A, Avataneo V, Manca A, Cusato J, De Nicolo A, Lucchini R, et al. 25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2. Nutrients. 2020;12(5).
13. 13. Liu N, Sun J, Wang X, Zhang T, Zhao M, Li H. Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis. Int J Infect Dis. 2021;104:58-64.
14. 14. Im JH, Je YS, Baek J, Chung MH, Kwon HY, Lee JS. Nutritional status of patients with COVID-19. Int J Infect Dis. 2020;100:390-3.
15. 15. Pereira M, Dantas Damascena A, Galvao Azevedo LM, de Almeida Oliveira T, da Mota Santana J. Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2020:1-9.
16. 16. Lau FH, Majumder R, Torabi R, Saeg F, Hoffman R, Cirillo JD, et al. Vitamin D insufficiency is prevalent in severe COVID-19. 2020:2020.04.24.20075838.
17. 17. Panagiotou G, Tee SA, Ihsan Y, Athar W, Marchitelli G, Kelly D, et al. Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity. Clin Endocrinol (Oxf). 2020;93(4):508-11.
18. 18. Sulli A, Gotelli E, Casabella A, Paolino S, Pizzorni C, Alessandri E, et al. Vitamin D and Lung Outcomes in Elderly COVID-19 Patients. Nutrients. 2021;13(3).
19. 19. Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583.
20. 20. Ling SF, Broad E, Murphy R, Pappachan JM, Pardesi-Newton S, Kong MF, et al. High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study. Nutrients. 2020;12(12).
21. 21. Murai IH, Fernandes AL, Sales LP, Pinto AJ, Goessler KF, Duran CSC, et al. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021;325(11):1053-60.
22. 22. Türkiye Endokrinoloji ve Metabolizma Derneği. Osteoporoz ve metabolik kemik hastalıkları tanı ve tedavi kılavuzu. 15.ed. Ankara;2020. Available from: https://temd.org.tr/admin/uploads/tbl_kilavuz/20210104143325-2021tbl_kilavuz5e76bb3d16.pdf.
23. 23. Rudneva LF, Androsova LA. [Long-term outcomes after acute vitamin D3 intoxication]. Vopr Pitan. 2004;73(4):11-3.
24. 24. Kashiouris MG, L'Heureux M, Cable CA, Fisher BJ, Leichtle SW, Fowler AA. The Emerging Role of Vitamin C as a Treatment for Sepsis. Nutrients. 2020;12(2).
25. 25. Maxfield L, Crane JS. Vitamin C Deficiency. StatPearls. Treasure Island (FL)2021.
26. 26. Bakan S, Deveboynu SN, Kartal FT. COVID-19 Pandemisinde Bağışıklık Üzerine Antioksidan Vitaminlerin Etkisi.3:140-8.
27. 27. Hemila H. Vitamin C and Infections. Nutrients. 2017;9(4).
28. 28. Carr AC, Maggini S. Vitamin C and Immune Function. Nutrients. 2017;9(11).
29. 29. Farjana M, Moni A, Sohag AAM, Hasan A, Hannan MA, Hossain MG, et al. Repositioning Vitamin C as a Promising Option to Alleviate Complications associated with COVID-19. Infect Chemother. 2020;52(4):461-77.
30. 30. Ferraro PM, Curhan GC, Gambaro G, Taylor EN. Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones. Am J Kidney Dis. 2016;67(3):400-7.
31. 31. Thomas LD, Elinder CG, Tiselius HG, Wolk A, Akesson A. Ascorbic acid supplements and kidney stone incidence among men: a prospective study. JAMA Intern Med. 2013;173(5):386-8.
32. 32. Fowler AA, 3rd, Syed AA, Knowlson S, Sculthorpe R, Farthing D, DeWilde C, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. 2014;12:32.
33. 33. Hiedra R, Lo KB, Elbashabsheh M, Gul F, Wright RM, Albano J, et al. The use of IV vitamin C for patients with COVID-19: a case series. Expert Rev Anti Infect Ther. 2020;18(12):1259-61.
34. 34. Zhao B, Ling Y, Li J, Peng Y, Huang J, Wang Y, et al. Beneficial aspects of high dose intravenous vitamin C on patients with COVID-19 pneumonia in severe condition: a retrospective case series study. Ann Palliat Med. 2021;10(2):1599-609.
35. 35. Zhang J, Rao X, Li Y, Zhu Y, Liu F, Guo G, et al. Pilot trial of high-dose vitamin C in critically ill COVID-19 patients. Ann Intensive Care. 2021;11(1):5.
36. 36. Thomas S, Patel D, Bittel B, Wolski K, Wang Q, Kumar A, et al. Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial. JAMA Netw Open. 2021;4(2):e210369.
37. 37. Kumari P, Dembra S, Dembra P, Bhawna F, Gul A, Ali B, et al. The Role of Vitamin C as Adjuvant Therapy in COVID-19. Cureus. 2020;12(11):e11779.